Sfoglia per Rivista JAMA ONCOLOGY
Rechallenge for Patients with RAS and BRAF Wild-Type Metastatic Colorectal Cancer with Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical Trial
2019 C. Cremolini, D. Rossini, E. Dell'Aquila, S. Lonardi, E. Conca, M. Del Re, A. Busico, F. Pietrantonio, R. Danesi, G. Aprile, E. Tamburini, C. Barone, G. Masi, F. Pantano, F. Pucci, D.C. Corsi, N. Pella, F. Bergamo, E. Rofi, C. Barbara, A. Falcone, D. Santini
Safety, Tolerability, and Management of Toxic Effects of Phosphatidylinositol 3-Kinase Inhibitor Treatment in Patients with Cancer: A Review
2019 A. Esposito, G. Viale, G. Curigliano
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination with Nivolumab for Patients with Advanced Solid Tumors : A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial
2020 K.M. Heinhuis, M. Carlino, M. Joerger, M. Di Nicola, T. Meniawy, S. Rottey, V. Moreno, A. Gazzah, J.-. Delord, L. Paz-Ares, C. Britschgi, R.J. Schilder, K. O'Byrne, G. Curigliano, E. Romano, P. Patah, R. Wang, Y. Liu, G. Bajaj, L.L. Siu
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile